Shareholders' Equity 
 Current liabilities: 
 Accounts payable                                                    $436                     $688                           $250 
  Accrued liabilities                                                 563                      404                            412 
  Warrant liability                                                   660                      390                            210 
 Deferred revenue                                                     501                      501                            501 
 Total current liabilities                                          2,160                    1,983                          1,373 
                                                  -----------------------  -----------------------  ----------------------------- 
 
 Other long-term liabilities                                        1,130                    1,632                          1,381 
                                                  -----------------------  -----------------------  ----------------------------- 
 Total liabilities                                                  3,290                    3,615                          2,754 
                                                  -----------------------  -----------------------  ----------------------------- 
 
 Equity 
 Common stock, at $0.001 par, 
  authorised 300 million at 6/30/14 
  and 12/31/13; 205.1 million shares 
  issued, 204.0 shares outstanding 
  (6/30/2014 and:168.8 million 
  shares issued, 167.7 million 
  shares outstanding at 12/31/13) 
  and 168.8 million shares issued 
  and outstanding at 6/30/13                                          205                      168                            168 
 Additional paid in capital                                        81,329                   78,377                         78,421 
 Accumulated deficit                                             (82,932)                 (77,747)                       (79,826) 
 Treasury stock of 1,084,413 common 
  stock 6/30/14, 
  12/31/13 and 6/30/13                                              (108)                    (108)                          (108) 
                                                  -----------------------  -----------------------  ----------------------------- 
 
  TyraTech Inc. shareholders' equity 
   (deficit)                                                      (1,506)                      690                        (1,345) 
   Non-controlling interest                                           (5)                      (5)                            (5) 
   Total shareholders' equity (deficit)                           (1,511)                      685                        (1,350) 
                                                  -----------------------  -----------------------  ----------------------------- 
 Total liabilities & shareholders' 
  equity (deficit) 
 
  The accompanying notes are an 
  integral part of these unaudited 
  interim consolidated financial 
  statements.                                                      $1,779                   $4,300                         $1,404 
                                                  -----------------------  -----------------------  ----------------------------- 
 
 

Consolidated Statements of Cash Flow

in $'000

 
 
                                                              (Unaudited) six months 
                                                                   ended 30 June 
                                                    ----------------------------------------- 
 
                                                                                                   Year ended 
                                                                                                  31 December 
                                                                2014                  2013               2013 
 Cash flows from operating activities: 
  Net loss                                                            $(3,106)       $(2,823)        $(4,902) 
 Adjustments to reconcile net 
  loss to net cash used in operating 
  activities: 
 Depreciation and amortisation                                              49             58             108 
 Amortisation of stock awards                                               71            117             162 
 Change in fair value of warrants                                          450            390             210 
  Net loss from unconsolidated 
   subsidiary                                                                -            217             359 
 Changes in operating assets and 
  liabilities: 
 Accounts receivable                                                     (536)           (66)              25 
 Inventory                                                               (204)              -            (46) 
  Prepaid expenses                                                          27             54            (69) 
  Accounts payable and accrued 
   liabilities                                                             337            449              18 
  Deposits                                                                 (1)              -               - 
 Deferred revenue                                                        (250)          (250)           (501) 
 
 Net cash used in operating 
  activities                                                             (3,163)      (1,854)             (4,636) 
                                                        --------------------------  ---------  ------------------ 
 
 Cash flows from investing activities: 
 Purchases of property and 
  equipment                                                                    (8)       (16)                (17) 
 Net cash used in investing 
  activities                                                                   (8)       (16)                (17) 
                                                        --------------------------  ---------  ------------------ 
 
 
 Cash flows from financing 
  activities: 
 Net proceeds from sale of 
  common stock                                                               2,874      3,979               3,978 
 Net cash provided by financing 
  activities                                                                 2,874      3,979               3,978 
                                                        --------------------------  ---------  ------------------ 
 
 Net increase (decrease) in cash 
  and cash equivalents                                                       (297)      2,109               (675) 
 Cash and cash equivalents beginning 
  of the period                                                                873      1,549               1,548 
                                                        --------------------------  ---------  ------------------ 
 Cash and cash equivalents end 
  of the period                                                               $576     $3,658                $873 
                                                        ==========================  =========  ================== 
 
 
 
 
          These accompanying notes are 
      an integral part of these unaudited 
         interim consolidated financial 
                  statements. 
 
 

Notes to the Interim Consolidated Financial Statements

   1.   Basis of Preparation 

The financial statements of TyraTech, Inc. and its subsidiaries (TyraTech Sustainable Solutions, LLC; and TyraChem, LLC) referred to as the "Company" have been prepared in accordance with accounting principles generally accepted in the United States of America (US GAAP) and the attached financial statements have been prepared on a consolidated basis.

The Company holds a 40% share of an unconsolidated jointly owned enterprise (Envance Technologies, LLC.) with AMVAC Chemical Corporation, a wholly owned subsidiary of American Vanguard Corporation. This unconsolidated entity is accounted for under the equity method of accounting.

The results for the year ended 31 December 2013 have been extracted from the statutory consolidated financial statements of TyraTech, Inc. for the year ended 31 December 2013 which were prepared in accordance with US GAAP.

The unaudited interim consolidated financial statements for the six months ended 30 June 2014 and 2013 were prepared on the basis of the accounting policies set out in the most recently published consolidated financial statements of the Company for the year ended 31 December 2013. As permitted, this interim report has been prepared in accordance with AIM rules. Certain information and note disclosures normally included in annual financial statements prepared in accordance with US GAAP have been omitted pursuant to the AIM's rules and regulations for interim reporting. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes for the year ended 31 December 2013.

   2.   Liquidity and Capital Resources 

At 30 June 2014 the Company had $575,000 (2013: $3,658,000) in cash and cash and cash equivalents and no indebtedness.

The Company has had significant negative cash flows from operating activities since inception. The Company is continuing to manage the magnitude of these negative operating cash flows through product sales expansion. The Company believes that with the existing cash on hand, cash expected from existing supply contracts, funding from prospective agreements, a continued focus on cost control, and a fundraise subsequent to the date of these statements (net $5.7 million), that the Company will have sufficient cash to meet its working capital needs; i.e., at least twelve months from the date of the approval of these Financial Statements. For this reason, the Directors consider it appropriate to continue to prepare the Statements on the going concern basis.

Tyratech (LSE:TYR)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Tyratech Charts.
Tyratech (LSE:TYR)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Tyratech Charts.